Pneumococcal infections are common in people living with HIV, even with higher CD4 cell counts. Vaccination and HIV treatment reduce the risk of invasive pneumococcal disease. Pneumococcal disease is ...

Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...

Children under five years of age, especially those aged two years or under, face a high risk of pneumococcal disease, which ...

Pneumococcal vaccines are the most effective way to protect yourself or your child against pneumococcal disease, and may help prevent infections including ear infections, pneumonia (lung infection ...

Vaxcyte is awaiting data from another vaccine candidate for invasive pneumococcal disease (IPD) before advancing to Phase III.

The downside comes after PCVX reports mixed results from a mid-stage study on its pneumococcal vaccine in infants.

EDT Vaxcyte (PCVX) sinks 35% to $45 after pneumococcal disease vaccine resultsDon't Miss Our End of Quarter Offers: Discover the latest ...

The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...

Multidrug resistance became a serious concern in the treatment of invasive pneumococcal diseases, especially in Asian countries. After PCV7 vaccination, serotype 19A has emerged as an important ...

The company is adopting a "portfolio strategy" to pneumococcal disease, with "tailored…vaccines to meet the specific needs of different populations," said Dr Eliav Barr, the drugmaker's chief ...

(Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it will hold a webcast ...

EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults “Pneumococcal disease continues to pose a significant risk for adults in Europe, among adults who are ...